Peak Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2015
For the six months, the company reported revenue was $382,292. Net loss was $1,405,296 against $862,374 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.5 USD | 0.00% | 0.00% | +160.12% |
1st Jan change | Capi. | |
---|---|---|
+160.12% | 94.16M | |
+11.31% | 87.43B | |
+7.52% | 79.69B | |
-11.27% | 56.79B | |
+23.30% | 47.14B | |
+32.46% | 46.62B | |
-26.51% | 45.5B | |
+81.90% | 42.31B | |
-6.42% | 25.81B | |
+21.21% | 22.27B |